lut014
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2019 (NCT03876106)
Timeline
Indications
Mechanism of action
BRAF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04759664 | Phase 2 | Apr 12, 2021 | Lutris Pharma Ltd. |
| NCT04261387 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2020 | Lutris Pharma Ltd. |
| NCT03876106 | Phase 1 | Mar 31, 2019 | Lutris Pharma Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lutris Pharma Ltd. | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1